Tag Archives: ULBI

Top 10 Blue Chip Stocks To Buy For 2019

September 6, 2018: Markets opened mixed Thursday with the Dow blue chips even bouncing out of the red to get on track for a modest daily gain. The energy and tech sectors led the day’s decline with defensive stocks putting up whatever good numbers there were. On the economic front, U.S. productivity growth reached a three-year high. Tomorrow’s report on the employment situation is expected to show 195,000 new jobs added in August and an unemployment rate of 3.8%.

WTI crude oil for October delivery settled at $67.77 a barrel, down 1.4% on the day following a mixed report on petroleum inventories. December gold added 0.3% to settle at $1,204.30. Equities were heading for a mixed close about 10 minutes before the bell as the Dow traded up 0.19% for the day, the S&P 500 traded down 0.27%, and the Nasdaq Composite traded down 0.83%.

Bitcoin futures (XBTU8) for September delivery traded at $6,400, down about 7.5% on the Cboe after opening at $6,915 this morning. The trading range today was $6,230 to $6,937.85.

Top 10 Blue Chip Stocks To Buy For 2019: Summit State Bank(SSBI)

Advisors’ Opinion:

  • [By Max Byerly]

    ValuEngine upgraded shares of Summit State Bank (NASDAQ:SSBI) from a hold rating to a buy rating in a research note released on Saturday.

    Separately, TheStreet raised Summit State Bank from a c+ rating to a b rating in a report on Wednesday, February 14th.

Top 10 Blue Chip Stocks To Buy For 2019: Questar Corporation(STR)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Staker (CURRENCY:STR) traded down 3.7% against the dollar during the 1 day period ending at 18:00 PM E.T. on February 26th. In the last week, Staker has traded down 4.3% against the dollar. One Staker token can currently be purchased for about $0.0024 or 0.00000061 BTC on major cryptocurrency exchanges. Staker has a total market capitalization of $3,175.00 and approximately $1.00 worth of Staker was traded on exchanges in the last 24 hours.

  • [By Shane Hupp]

    Staker (CURRENCY:STR) traded 12% higher against the US dollar during the twenty-four hour period ending at 17:00 PM Eastern on February 2nd. One Staker token can currently be bought for $0.0059 or 0.00000169 BTC on popular exchanges. Staker has a total market cap of $7,826.00 and approximately $19.00 worth of Staker was traded on exchanges in the last 24 hours. Over the last seven days, Staker has traded down 10.5% against the US dollar.

Top 10 Blue Chip Stocks To Buy For 2019: Rockwell Medical Technologies Inc.(RMTI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Zoe's Kitchen, Inc. (NYSE: ZOES) fell 27.8 percent to $10.45 in pre-market trading after the company reported weaker-than-expected earnings for its first quarter. The company also lowered its FY18 sales outlook from $358million-$368 million to $345 million-$352 million.
    Hibbett Sports, Inc. (NASDAQ: HIBB) shares fell 15.6 percent to $24.50 in pre-market trading after the company reported weaker-than-expected results for its first quarter.
    Rockwell Medical, Inc. (NASDAQ: RMTI) fell 15.5 percent to $5.02 in the pre-market trading session after the company disclosed that its President and CEO Robert Chioini was terminated.
    BG Staffing Inc (NYSE: BGSF) shares fell 12.7 percent to $19.00 in pre-market trading after reporting a common stock offering.
    8×8, Inc. (NASDAQ: EGHT) fell 9.3 percent to $20.00 in pre-market trading after reporting downbeat quarterly earnings.
    Asia Pacific Wire & Cable Corporation Limited (NASDAQ: APWC) fell 7.7 percent to $2.35 in pre-market trading after rising 3.88 percent on Thursday.
    Gap, Inc. (NYSE: GPS) shares fell 7.5 percent to $30.49 in pre-market trading after the company posted downbeat earnings for its first quarter on Thursday. Comps were up 1 percent in the quarter.
    California Resources Corporation (NYSE: CRC) fell 6.4 percent to $33.91 in pre-market trading.
    Buckle Inc (NYSE: BKE) fell 4.9 percent to $24.50 in pre-market trading following weak quarterly sales.
    China Rapid Finance Limited (NYSE: XRF) shares fell 4.9 percent to $3.13 in pre-market trading after climbing 11.53 percent on Thursday.
    Ross Stores, Inc. (NASDAQ: ROST) fell 4.8 percent to $78.98 in pre-market trading. Ross Stores reported upbeat earnings for its first quarter, but issued weak forecast for the current quarter.
    Callon Petroleum Company (NYSE: CPE) shares fell 4.7 percent to $11.90 in pre-market trading after the company reported pricing of common

  • [By Max Byerly]

    These are some of the media headlines that may have impacted Accern Sentiment Analysis’s scoring:

    Get Rockwell Medical alerts:

    Rockwell Alert: Bernstein Liebhard LLP Announces Investigation Of Rockwell Medical, Inc. – RMTI (finance.yahoo.com) Rockwell Medical countersues former CEO, CFO (modernhealthcare.com) Rockwell Medical sues former execs over alleged self-enriching behavior (seekingalpha.com) Is it time to Follow Now? Rockwell Medical, Inc. (RMTI) (connectinginvestor.com) Insider Buying: Rockwell Medical Inc (RMTI) Insider Purchases 12,561 Shares of Stock (americanbankingnews.com)

    Several research firms have recently issued reports on RMTI. BidaskClub upgraded shares of Rockwell Medical from a “sell” rating to a “hold” rating in a report on Tuesday, March 13th. Zacks Investment Research downgraded shares of Rockwell Medical from a “hold” rating to a “sell” rating in a report on Thursday, May 17th. Finally, ValuEngine upgraded shares of Rockwell Medical from a “sell” rating to a “hold” rating in a report on Wednesday, June 27th.

  • [By Stephan Byrd]

    Dynatronics (NASDAQ: DYNT) and Rockwell Medical (NASDAQ:RMTI) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, valuation, profitability, dividends and earnings.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Rockwell Medical (RMTI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Rockwell Medical (RMTI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Blue Chip Stocks To Buy For 2019: Ultralife Corporation(ULBI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Polar Power (NASDAQ: POLA) and Ultralife (NASDAQ:ULBI) are both small-cap utilities companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation.

Top 10 Blue Chip Stocks To Buy For 2019: Advent Claymore Convertible Securities and Income Fund(AVK)

Advisors’ Opinion:

  • [By Max Byerly]

    Saba Capital Management L.P. lessened its stake in Advent Claymore Convertible Sec & Inc Fd (NYSE:AVK) by 91.1% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 25,101 shares of the investment management company’s stock after selling 255,542 shares during the period. Saba Capital Management L.P. owned 0.11% of Advent Claymore Convertible Sec & Inc Fd worth $384,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Ethan Ryder]

    Advent Claymore Convertible Sec & Inc Fd (NYSE:AVK) insider Tracy V. Maitland purchased 50,000 shares of Advent Claymore Convertible Sec & Inc Fd stock in a transaction dated Thursday, September 6th. The shares were acquired at an average cost of $15.68 per share, for a total transaction of $784,000.00. Following the completion of the transaction, the insider now owns 12,000 shares of the company’s stock, valued at approximately $188,160. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

  • [By Ethan Ryder]

    Advent Claymore Convertible Sec & Inc Fd (NYSE:AVK) VP Tony Huang bought 2,066 shares of the business’s stock in a transaction dated Wednesday, September 5th. The stock was acquired at an average cost of $15.66 per share, for a total transaction of $32,353.56. Following the completion of the acquisition, the vice president now directly owns 7,100 shares in the company, valued at $111,186. The purchase was disclosed in a legal filing with the SEC, which is available through this link.

Top 10 Blue Chip Stocks To Buy For 2019: RetailMeNot, Inc.(SALE)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Headlines about RetailMeNot (NASDAQ:SALE) have been trending somewhat positive this week, according to Accern Sentiment. The research group rates the sentiment of press coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. RetailMeNot earned a news sentiment score of 0.18 on Accern’s scale. Accern also gave news headlines about the technology company an impact score of 45.6302865418039 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

Top 10 Blue Chip Stocks To Buy For 2019: Liberty Property Trust(LPT)

Advisors’ Opinion:

  • [By Max Byerly]

    DiamondRock Hospitality (NYSE:DRH) and Liberty Property Trust (NYSE:LPT) are both mid-cap finance companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, earnings, profitability, valuation and dividends.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Liberty Property Trust (LPT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    DekaBank Deutsche Girozentrale lowered its position in shares of Liberty Property Trust (NYSE:LPT) by 11.7% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 12,176 shares of the real estate investment trust’s stock after selling 1,608 shares during the period. DekaBank Deutsche Girozentrale’s holdings in Liberty Property Trust were worth $515,000 as of its most recent SEC filing.

Top 10 Blue Chip Stocks To Buy For 2019: j2 Global, Inc.(JCOM)

Advisors’ Opinion:

  • [By Ethan Ryder]

    J2 Global (NASDAQ:JCOM) Director W Brian Kretzmer sold 5,942 shares of the stock in a transaction on Wednesday, May 9th. The stock was sold at an average price of $87.25, for a total value of $518,439.50. Following the transaction, the director now owns 6,764 shares of the company’s stock, valued at $590,159. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

  • [By Ethan Ryder]

    OppenheimerFunds Inc. grew its stake in J2 Global Inc (NASDAQ:JCOM) by 2.7% during the second quarter, HoldingsChannel.com reports. The fund owned 417,643 shares of the technology company’s stock after acquiring an additional 11,122 shares during the quarter. OppenheimerFunds Inc.’s holdings in J2 Global were worth $36,173,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on J2 Global (JCOM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Shares of J2 Global Inc (NASDAQ:JCOM) rose 8.9% during trading on Wednesday following a better than expected earnings announcement. The stock traded as high as $83.40 and last traded at $81.88. Approximately 1,543,553 shares traded hands during trading, an increase of 320% from the average daily volume of 367,818 shares. The stock had previously closed at $75.19.

Top 10 Blue Chip Stocks To Buy For 2019: Canadian Pacific Railway Limited(CP)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Canadian Pacific Railway Limited (NYSE:CP) (TSE:CP) – Desjardins lifted their Q3 2018 earnings per share (EPS) estimates for Canadian Pacific Railway in a research note issued to investors on Monday, October 8th. Desjardins analyst B. Poirier now forecasts that the transportation company will post earnings of $3.16 per share for the quarter, up from their previous estimate of $2.79. Desjardins also issued estimates for Canadian Pacific Railway’s FY2020 earnings at $13.61 EPS and FY2021 earnings at $15.05 EPS.

  • [By Ethan Ryder]

    Canadian Pacific Railway (NYSE:CP) (TSE:CP) had its price target raised by equities researchers at Cowen from $225.00 to $236.00 in a research report issued on Monday. The brokerage presently has an “outperform” rating on the transportation company’s stock. Cowen’s price target would suggest a potential upside of 7.86% from the company’s current price.

  • [By Logan Wallace]

    TD Securities upgraded shares of Canadian Pacific Railway (TSE:CP) (NYSE:CP) from a hold rating to a buy rating in a report issued on Friday morning. The firm currently has C$325.00 target price on the stock, up from their prior target price of C$290.00.

  • [By Tyler Crowe]

    After an incredible fourth quarter, the first quarter of 2018 wasn’t Canadian Pacific’s (NYSE:CP) finest showing. While carloads and revenue continue to increase, operating costs are growing faster. If that weren’t enough of a concern, management has been notified that its union workers intend to strike in the coming days. 

  • [By Shane Hupp]

    Shares of Canadian Pacific Railway Limited (TSE:CP) (NYSE:CP) have received an average rating of “Buy” from the twelve analysts that are covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is C$258.00.

Top 10 Blue Chip Stocks To Buy For 2019: Intercontinental Exchange Inc.(ICE)

Advisors’ Opinion:

  • [By Todd Campbell]

    Owned by the Intercontinental Exchange (NYSE:ICE), the New York Stock Exchange is the largest stock market exchange in the world. Founded in 1792, the exchange has a long-standing reputation for executing transactions reliably, and for this reason, over 2,400 companies list their shares on it. 

  • [By Motley Fool Transcribing]

    Intercontinental Exchange (NYSE:ICE) Q4 2018 Earnings Conference CallFeb. 7, 2019 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Logan Wallace]

    iDice (CURRENCY:ICE) traded down 3.3% against the U.S. dollar during the 24-hour period ending at 21:00 PM E.T. on April 20th. iDice has a total market cap of $85,719.00 and approximately $0.00 worth of iDice was traded on exchanges in the last 24 hours. Over the last seven days, iDice has traded 21.8% higher against the U.S. dollar. One iDice token can currently be bought for about $0.0546 or 0.00000680 BTC on exchanges including CoinExchange and Mercatox.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Intercontinental Exchange (ICE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Matthew DiLallo]

    Last year was a record-setting one for Intercontinental Exchange (NYSE:ICE), or ICE. The global exchange operator’s revenue rose double digits during the fourth quarter, pushing its full-year number up more than 7% to a record level and marking its 13th straight year of revenue growth. The company also generated a record amount of cash flow, $1.8 billion of which it sent back to shareholders, the highest level in its history.

Top 10 Value Stocks To Watch For 2019

Wall Street is stunned after General Electric’s board of directors replaced John Flannery as chief executive with former Danaher CEO Lawrence Culp on Monday.

Flannery, who took the reins at GE in August 2017, was brought in to help turn around the struggling industrial conglomerate after a 16-year tenure by Jeff Immelt.

Though Wall Street first applauded Flannery’s move to embark on a deep dive into the company’s businesses and finances at the start of his term, the board eventually grew unsatisfied with the pace of his execution.

Culp is expected to continue the spinoff of GE’s health-care segment following a similar strategy in its railroad business.

General Electric’s shares, once a longtime favorite for an attractive dividend, have lost nearly half of their value over the past year despite management’s efforts.

Top 10 Value Stocks To Watch For 2019: Mattersight Corporation(MATR)

Advisors’ Opinion:

  • [By Joseph Griffin]

    KEYW (NASDAQ: KEYW) and Mattersight (NASDAQ:MATR) are both small-cap computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, valuation, dividends, analyst recommendations and risk.

  • [By Stephan Byrd]

    Mattersight (NASDAQ: MATR) and Simulations Plus (NASDAQ:SLP) are both small-cap computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, risk, institutional ownership, earnings and analyst recommendations.

  • [By Lisa Levin] Gainers
    Axsome Therapeutics, Inc. (NASDAQ: AXSM) rose 22.6 percent to $3.25 in pre-market trading after the company disclosed a positive outcome of the interim analysis of STRIDE-1 Phase 3 trial of AXS-05 in treatment resistant depression.
    Mattersight Corporation (NASDAQ: MATR) shares rose 23.2 percent to $2.65 in pre-market trading after the company agreed to be purchased by NICE Ltd.
    Comstock Resources, Inc. (NYSE: CRK) rose 21.2 percent to $5.77 in pre-market trading after the company disclosed a deal to buy oil & gas properties in North Dakota from Arkoma, Williston Drilling for about $620 million. The company also announced withdrawal of tender offers for outstanding secured notes.
    Chipotle Mexican Grill, Inc. (NYSE: CMG) rose 13.7 percent to $386.00 in pre-market trading as the company reported stronger-than-expected results for its first quarter on Wednesday.
    Quantenna Communications, Inc. (NASDAQ: QTNA) shares rose 12.6 percent to $14.70 in pre-market trading. Quantenna is expected to release Q1 results on April 30..
    BioTelemetry, Inc. (NASDAQ: BEAT) rose 11.1 percent to $37.50 in pre-market trading as the company reported stronger-than-expected earnings for its first quarter.
    Penn National Gaming, Inc. (NASDAQ: PENN) rose 10.4 percent to $29.00 in pre-market trading after reporting strong Q1 results.
    O'Reilly Automotive, Inc. (NASDAQ: ORLY) rose 9.8 percent to $250.00 in pre-market trading following upbeat Q1 profit.
    Advanced Micro Devices, Inc. (NASDAQ: AMD) shares rose 9.4 percent to $10.62 in pre-market trading as the company reported upbeat results for its first quarter.
    CYS Investments, Inc. (NYSE: CYS) rose 9.1 percent to $7.22 in pre-market trading after the company agreed to be acquired by Two Harbors Investment Corp (NYSE: TWO).
    GNC Holdings, Inc. (NYSE: GNC) rose 8.3 percent to $4.18 in pre-market trading after reporting Q1 results.
    Domino's Pizza, Inc. (NYSE: DPZ) shares rose 7.6 percent to $251.2
  • [By Shane Hupp]

    Ebix (NASDAQ: EBIX) and Mattersight (NASDAQ:MATR) are both computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, risk, earnings, analyst recommendations, dividends and valuation.

  • [By Lisa Levin]

    Shares of Mattersight Corporation (NASDAQ: MATR) got a boost, shooting up 23 percent to $2.65 after the company agreed to be purchased by NICE Ltd.

Top 10 Value Stocks To Watch For 2019: BioScrip, Inc.(BIOS)

Advisors’ Opinion:

  • [By Logan Wallace]

    BioScrip (NASDAQ: BIOS) and Chemed (NYSE:CHE) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, analyst recommendations and risk.

  • [By Shane Hupp]

    BioScrip (NASDAQ: BIOS) and Amedisys Home Health and Hospice Care (NASDAQ:AMED) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, earnings, dividends and risk.

  • [By Shane Hupp]

    BiosCrypto (CURRENCY:BIOS) traded flat against the US dollar during the 24 hour period ending at 22:00 PM E.T. on June 14th. BiosCrypto has a total market cap of $26,890.00 and $0.00 worth of BiosCrypto was traded on exchanges in the last day. One BiosCrypto coin can now be bought for approximately $0.0013 or 0.00000017 BTC on major exchanges. In the last week, BiosCrypto has traded down 13.4% against the US dollar.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on BioScrip (BIOS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Money Morning News Team]

    BioScrip Inc. (Nasdaq: BIOS) provides at-home medical care and services across the United States.

    BIOS’s central profit opportunity is in the rapid growth of the pharmaceutical industry. The pharmaceutical market is currently worth $12 billion and is expected to grow at an annual rate of five to seven percent.

Top 10 Value Stocks To Watch For 2019: NBT Bancorp Inc.(NBTB)

Advisors’ Opinion:

  • [By Ethan Ryder]

    NBT Bancorp (NASDAQ:NBTB) was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating in a note issued to investors on Saturday.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on NBT Bancorp (NBTB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on NBT Bancorp (NBTB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Value Stocks To Watch For 2019: WVS Financial Corp.(WVFC)

Advisors’ Opinion:

Top 10 Value Stocks To Watch For 2019: Abengoa Yield plc(ABY)

Advisors’ Opinion:

  • [By Stephan Byrd]

    ArtByte (ABY) is a proof-of-work (PoW) coin that uses the Scrypt hashing algorithm. It was first traded on May 1st, 2014. ArtByte’s total supply is 792,537,250 coins. ArtByte’s official website is www.artbyte.me. ArtByte’s official Twitter account is @artbyteme and its Facebook page is accessible here. The Reddit community for ArtByte is /r/ArtByte and the currency’s Github account can be viewed here.

  • [By Logan Wallace]

    ArtByte (CURRENCY:ABY) traded up 10.8% against the dollar during the 1-day period ending at 20:00 PM ET on June 14th. ArtByte has a market capitalization of $3.84 million and approximately $13,004.00 worth of ArtByte was traded on exchanges in the last 24 hours. One ArtByte coin can currently be purchased for $0.0048 or 0.00000073 BTC on popular cryptocurrency exchanges including Bittrex, Cryptopia and LiteBit.eu. Over the last week, ArtByte has traded 16.9% lower against the dollar.

  • [By Logan Wallace]

    ArtByte (CURRENCY:ABY) traded down 8% against the dollar during the 1 day period ending at 17:00 PM Eastern on September 6th. During the last week, ArtByte has traded 11.3% higher against the dollar. One ArtByte coin can currently be purchased for about $0.0029 or 0.00000045 BTC on popular cryptocurrency exchanges including LiteBit.eu, Bittrex and Cryptopia. ArtByte has a total market cap of $2.31 million and approximately $4,225.00 worth of ArtByte was traded on exchanges in the last day.

Top 10 Value Stocks To Watch For 2019: Ultralife Corporation(ULBI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Polar Power (NASDAQ: POLA) and Ultralife (NASDAQ:ULBI) are both small-cap utilities companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation.

Top 10 Value Stocks To Watch For 2019: Apache Corporation(APA)

Advisors’ Opinion:

  • [By Logan Wallace]

    Apache (NYSE:APA)‘s stock had its “hold” rating reaffirmed by research analysts at Stifel Nicolaus in a report released on Thursday. They presently have a $49.00 price target on the energy company’s stock. Stifel Nicolaus’ target price suggests a potential upside of 11.80% from the company’s current price.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close was Apache Corp. (NYSE: APA) which rose over 5% to $41.75. The stock’s 52-week range is $33.60 to $51.21. Volume was 4.8 million compared to the daily average volume of 4.4 million.

  • [By Matthew DiLallo]

    In addition, the company continues to find needle-moving expansion projects, having recently unveiled the development of the Permian Highway Pipeline Project. Kinder Morgan is developing the $2 billion natural gas pipeline with private equity-backed EagleClaw Midstream and Apache Corporation (NYSE:APA). It’s a follow-up to the Gulf Coast Express Pipeline (CGX), which is a $1.75 billion gas pipeline it’s building with two other midstream companies and Apache. Kinder Morgan has already started work on GCX, which should be in service by October 2019, while PHP could follow a year later if the company gives it the green light. These projects will help offset some of the growth it will lose by selling Trans Mountain.

  • [By Paul Ausick]

    Apache Corp. (NYSE: APA) dropped about 7.3% Thursday to post a new 52-week low of $34.50. Shares closed at $37.20 on Wednesday and the stock’s 52-week high is $55.23. Volume was over 11 million, about three times the daily average of around 3.9 million. The company reported quarterly results this morning, but investors were not impressed.

Top 10 Value Stocks To Watch For 2019: Beazer Homes USA, Inc.(BZH)

Advisors’ Opinion:

  • [By Shane Hupp]

    Beazer Homes USA (NYSE:BZH) was downgraded by analysts at JPMorgan Chase & Co. from an overweight rating to a neutral rating. The firm currently has $13.00 price target on the stock, down from their previous price target of $18.00.

  • [By Tyler Crowe]

    There have been some macroeconomic signs that America’s housing boom is starting to show signs of fatigue, but those figures haven’t really shown up in the earnings reports of most homebuilders. The one exception is Beazer Homes USA (NYSE:BZH). While most companies are still showing strong home sales and growing net orders, Beazer’s fiscal third-quarter results showed some cracks in its growth trajectory.

  • [By Joseph Griffin]

    Shares of Beazer Homes USA, Inc. (NYSE:BZH) dropped 5.9% during mid-day trading on Wednesday . The company traded as low as $14.95 and last traded at $15.02. Approximately 582,100 shares traded hands during trading, an increase of 3% from the average daily volume of 566,087 shares. The stock had previously closed at $15.96.

Top 10 Value Stocks To Watch For 2019: Ligand Pharmaceuticals Incorporated(LGND)

Advisors’ Opinion:

  • [By Stephan Byrd]

    New York State Common Retirement Fund raised its stake in shares of Ligand Pharmaceuticals Inc. (NASDAQ:LGND) by 30.7% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 56,216 shares of the biotechnology company’s stock after purchasing an additional 13,219 shares during the period. New York State Common Retirement Fund owned 0.27% of Ligand Pharmaceuticals worth $9,285,000 at the end of the most recent quarter.

  • [By Jon C. Ogg]

    Ligand Pharmaceuticals Inc. (NASDAQ: LGND) was maintained as Buy at Argus, but the firm lowered its target to $150 from $200. The independent research firm noted that recent weakness offers a buying opportunity as the company is believed to be on track to post solid earnings growth over the next several years. Ligand closed up 1.5% at $119.76 on Tuesday, in a 52-week range of $98.56 to $278.62.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Ligand Pharmaceuticals (LGND)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Ligand Pharmaceuticals (LGND)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Transcribers]

    Ligand Pharmaceuticals Inc  (NASDAQ:LGND)Q4 2018 Earnings Conference CallFeb. 07, 2019, 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Joseph Griffin]

    Ligand Pharmaceuticals Inc. (NASDAQ:LGND) COO Matthew W. Foehr sold 12,000 shares of the firm’s stock in a transaction that occurred on Monday, October 1st. The stock was sold at an average price of $273.88, for a total transaction of $3,286,560.00. Following the transaction, the chief operating officer now directly owns 105,388 shares of the company’s stock, valued at $28,863,665.44. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

Top 10 Value Stocks To Watch For 2019: Masonite International Corporation(DOOR)

Advisors’ Opinion:

  • [By Matt Hogan]

    Masonite International Corp (NYSE: DOOR) supplies exterior and interior doors primarily to the North American residential market. There are in a great position to profit from both new construction and the repair, renovation, and remodel ("RRR") trends of a hot real estate market.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Masonite International (DOOR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Masonite International (NYSE:DOOR) was upgraded by analysts at ValuEngine from a sell rating to a hold rating.

    Edgewell Personal Care (NYSE:EPC) was upgraded by analysts at Zacks Investment Research from a sell rating to a buy rating. Zacks Investment Research currently has $63.00 target price on the stock. According to Zacks, “Edgewell Personal Care Co. manufactures and markets personal care products. The company’s brand consists of Schick(R) and Wilkinson Sword(R) men’s and women’s shaving systems and disposable razors; Edge(R) and Skintimate(R) shave preparations; Playtex(R), Stayfree(R), Carefree(R) and o.b. (R) feminine care products; Banana Boat(R) and Hawaiian Tropic(R) sun care products; Playtex(R) infant feeding, Diaper Genie(R) and gloves; Wet Ones(R) moist wipes. Edgewell Personal Care Co., formerly known as Energizer Holdings, is based in St Louis, United States. “

Top Warren Buffett Stocks To Invest In Right Now

Tell us how you really feel, Mr. Buffett.

The price of bitcoin took a dive after Warren Buffett renewed his criticism of the cryptocurrency even comparing it to rat poison.

Bitcoin had been closing in on $10,000, but it fell nearly 6% Sunday and was down another 2% Monday to just over $9,300.

Buffett, the CEO of Berkshire Hathaway (BRKB), has been a bitcoin bear for years. He has often compared the cryptocurrency to gold, saying that both assets are strictly speculative and don’t produce earnings and dividends like stocks do.

Before the Berkshire annual meeting on Saturday, Buffett told CNBC that bitcoin was “probably rat poison squared.”

During the meeting itself, Buffett joked that “if you had bought gold at the time of Christ and you figure the compound rate on it, it’s a couple tenths of a percent.” What Buffett was saying about bitcoin was that you can buy it, but it will never produce anything of value.

He also responded to a question from the audience about bitcoin by saying that it and other crytpocurrencies “will come to bad endings.”

Top Warren Buffett Stocks To Invest In Right Now: Ultralife Corporation(ULBI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Polar Power (NASDAQ: POLA) and Ultralife (NASDAQ:ULBI) are both small-cap utilities companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation.

Top Warren Buffett Stocks To Invest In Right Now: United Fire Group, Inc(UFCS)

Advisors’ Opinion:

  • [By Shane Hupp]

    United Fire & Casualty (NASDAQ:UFCS) shares hit a new 52-week high and low during mid-day trading on Friday . The stock traded as low as $53.47 and last traded at $53.26, with a volume of 1018 shares trading hands. The stock had previously closed at $51.84.

  • [By Lee Jackson]

    United Fire Group Inc. (NASDAQ: UFCS) was downgraded to hold from buy at Sandler ONeill. The 52-week trading range for the shares has been $38.95 to $58.46. The stock closed Monday at $56, so this could be another valuation call.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on United Fire Group (UFCS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Earnest Partners LLC grew its stake in shares of United Fire Group, Inc. (NASDAQ:UFCS) by 2.6% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,449,353 shares of the insurance provider’s stock after acquiring an additional 36,932 shares during the quarter. Earnest Partners LLC owned about 0.06% of United Fire Group worth $69,366,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    United Fire Group (NASDAQ:UFCS) was downgraded by stock analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Friday.

  • [By Shane Hupp]

    Shares of United Fire & Casualty (NASDAQ:UFCS) hit a new 52-week high and low during trading on Thursday following a dividend announcement from the company. The company traded as low as $52.90 and last traded at $52.61, with a volume of 2181 shares trading hands. The stock had previously closed at $51.78.

Top Warren Buffett Stocks To Invest In Right Now: Ultragenyx Pharmaceutical Inc.(RARE)

Advisors’ Opinion:

  • [By Chris Lange]

    Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) is expected to report Phase 2 data from all its tumor-induced osteomalacia patients. Shares of Ultragenyx closed Friday at $76.87, in a 52-week range of $41.67 to $86.10 and with a consensus analyst target of $68.74.

  • [By Shane Hupp]

    These are some of the media headlines that may have effected Accern’s scoring:

    Get Ultragenyx Pharmaceutical alerts:

    Burosumab Improves Outcomes in Children with XLH in Phase 2 Trial (raredr.com) RARE Stock Is on the Verge of Breaking Out Toward Higher Prices (profitconfidential.com) Burosumab may benefit children with X-linked hypophosphatemia (medicalxpress.com) A Look Inside the Quant Data For Ultragenyx Pharmaceutical Inc. (NasdaqGS:RARE) (parkcitycaller.com) Ultragenyx Pharmaceutical Inc. (RARE)- Stock in the Trader’s Radar (nasdaqfortune.com)

    A number of research firms have recently weighed in on RARE. ValuEngine raised Ultragenyx Pharmaceutical from a “hold” rating to a “buy” rating in a report on Saturday. BidaskClub raised Ultragenyx Pharmaceutical from a “buy” rating to a “strong-buy” rating in a report on Saturday, May 19th. Barclays raised Ultragenyx Pharmaceutical from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $62.00 to $74.00 in a report on Friday, May 11th. Goldman Sachs Group began coverage on Ultragenyx Pharmaceutical in a report on Thursday, May 10th. They set a “neutral” rating and a $63.00 target price for the company. Finally, Zacks Investment Research downgraded Ultragenyx Pharmaceutical from a “hold” rating to a “sell” rating in a report on Tuesday, January 30th. One research analyst has rated the stock with a sell rating, four have issued a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $70.06.

  • [By Todd Campbell]

    A Genentech alumnus, Conner was previously vice president of clinical science at Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biotech that has successfully developed therapies for rare and ultrarare diseases. Prior to that, he was senior medical director at BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), another biotech company that’s successfully developed drugs for rare diseases.

  • [By Joseph Griffin]

    BidaskClub upgraded shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) from a hold rating to a buy rating in a report released on Monday.

    A number of other brokerages have also recently weighed in on RARE. JPMorgan Chase restated an overweight rating and issued a $66.00 price objective (down from $68.00) on shares of Ultragenyx Pharmaceutical in a research note on Wednesday, February 21st. Evercore ISI upgraded shares of Ultragenyx Pharmaceutical from an in-line rating to an outperform rating in a research note on Monday, January 22nd. Stifel Nicolaus restated a buy rating and issued a $74.00 price objective (down from $85.00) on shares of Ultragenyx Pharmaceutical in a research note on Wednesday, February 21st. ValuEngine upgraded shares of Ultragenyx Pharmaceutical from a sell rating to a hold rating in a research note on Wednesday, April 4th. Finally, Wedbush reiterated a positive rating and set a $71.00 target price (up from $64.00) on shares of Ultragenyx Pharmaceutical in a research note on Wednesday, April 18th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company. Ultragenyx Pharmaceutical presently has a consensus rating of Buy and an average price target of $69.76.

Top Warren Buffett Stocks To Invest In Right Now: Lexington Realty Trust(LXP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Lexington Realty Trust (NYSE:LXP) is scheduled to be releasing its earnings data before the market opens on Tuesday, May 8th. Analysts expect Lexington Realty Trust to post earnings of $0.06 per share for the quarter. Lexington Realty Trust has set its FY18 guidance at $0.95-0.98 EPS.

  • [By Max Byerly]

    ValuEngine upgraded shares of Lexington Realty Trust (NYSE:LXP) from a strong sell rating to a sell rating in a research note released on Friday.

    Several other brokerages have also weighed in on LXP. Stifel Nicolaus lowered Lexington Realty Trust from a hold rating to a sell rating and cut their price target for the company from $8.50 to $7.00 in a research note on Tuesday, May 8th. Zacks Investment Research upgraded Lexington Realty Trust from a sell rating to a hold rating in a research note on Saturday, May 12th. Barclays cut their price target on Lexington Realty Trust from $10.00 to $9.00 and set an underweight rating for the company in a research note on Tuesday, March 20th. Wells Fargo & Co cut their price target on Lexington Realty Trust from $11.00 to $9.00 and set a market perform rating for the company in a research note on Monday, March 19th. Finally, JPMorgan Chase & Co. lowered their price objective on Lexington Realty Trust from $10.00 to $9.00 and set a neutral rating on the stock in a report on Tuesday, April 10th. Four equities research analysts have rated the stock with a sell rating and eight have assigned a hold rating to the stock. Lexington Realty Trust has a consensus rating of Hold and an average price target of $9.68.

  • [By Ethan Ryder]

    Lexington Realty Trust (NYSE:LXP) was downgraded by equities researchers at Stifel Nicolaus from a “hold” rating to a “sell” rating in a note issued to investors on Tuesday, MarketBeat reports. They currently have a $7.00 target price on the real estate investment trust’s stock, down from their previous target price of $8.50. Stifel Nicolaus’ price target suggests a potential downside of 15.66% from the stock’s current price.

Top 10 Heal Care Stocks To Buy Right Now

After examining Walt Disney’s (DIS) earnings, which were released after yesterday’s market close, Stifel’s Benjamin Mogil and Kevin Lee Hon Siong argued that they “continue to view Disney as a Tale of Two Stories.” They explain why:

Getty Images

Disney reported 4Q16 results which were in-line with our estimates but below those of consensus expectations. Commentary for 2017 was likely below expectations but at the same set the stage for more realistic expectations and we view that clarity/transparency as one of the bigger factors behind the after-market hours stock reversal.

Continue To View Disney As A Tale Of Two Stories: Since the beginning of the year we noted that the company is somewhat of a split story. We continue to be of the view that the consumer-facing segments of the business: theme parks, studio and consumer products, continue to execute well/have a favorable outlook. Noted on this call was a strong start to Shanghai Disney, with the park expected to be around break even by the end of the year, much quicker than other international parks. While Studio will see a down year given the difficult “Star Wars” comp, the Studio continues to have a strong content cycle from not only Marvel, Star Wars and Pixar but increasingly from Disney Animation and Disney live action with the setup into 2018 very favorable. Similarly, the commentary on consumer products growth y/y was better than expected and shows greater depth into its product/licensing offering.

Top 10 Heal Care Stocks To Buy Right Now: Data I/O Corporation(DAIO)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Wednesday, technology shares fell 2.51 percent. Meanwhile, top losers in the sector included Autodesk, Inc. (NASDAQ: ADSK), down 15 percent, and Data I/O Corporation (NASDAQ: DAIO) down 13 percent.

Top 10 Heal Care Stocks To Buy Right Now: Integrated Device Technology, Inc.(IDTI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

    Analysts are expecting Discovery Communications Inc. (NASDAQ: DISCA) to have earned $0.47 per share on revenue of $1.69 billion in the latest quarter. Discovery Communications shares rose 0.17 percent to $29.08 in after-hours trading.
    Analysts expect T-Mobile US Inc (NASDAQ: TMUS) to report

  • [By Lisa Levin]

     

    T-Mobile US Inc (NYSE: TMUS) reported upbeat earnings for its fourth quarter on Tuesday.
    Integrated Device Technology Inc (NASDAQ: IDTI) agreed to acquire GigPeak Inc (NYSE: GIG) for around $250 million in cash.
    Charles River Laboratories Intl. Inc (NYSE: CRL) reported better-than-expected profit for its fourth quarter.
    Amkor Technology, Inc. (NASDAQ: AMKR) posted downbeat revenue for its fourth quarter and issued a weak outlook for the current quarter.

Top 10 Heal Care Stocks To Buy Right Now: Brown(n)

Advisors’ Opinion:

  • [By Arie Goren]

    On November 5, Oracle (NYSE:ORCL)confirmed that it has finally completed the acquisition of Netsuite (NYSE:N) for $9.3 billion in cash, or $109 per share that the company had initially offered. In my previous article about Oracle, I had suggested that the acquisition of NetSuite, the cloud business application software company, is a smart move by Oracle. What’s more, it is not paying an excessive price for the deal. In fact, Oracle insisted that it will not pay more than what it had first offered despite the resistance from T Rowe Price (NSDQ:TROW)which demanded $133 per share.

Top 10 Heal Care Stocks To Buy Right Now: Eagle Bancorp, Inc.(EGBN)

Advisors’ Opinion:

  • [By Paul Ausick]

    Eagle Bancorp Inc. (NASDAQ: EGBN) dropped 28% Friday to post a new 52-week low of $47.65 after closing at $66.15 on Thursday. The stock’s 52-week high is $69.80. Volume of around 3.6 million was more than three times the daily average. The bank holding company had no specific news Friday.

  • [By Lisa Levin]

    On Monday, the financial sector proved to be a source of strength for the market. Leading the sector was strength from Eagle Bancorp, Inc. (NASDAQ: EGBN) and BankUnited (NYSE: BKU).

Top 10 Heal Care Stocks To Buy Right Now: Ultralife Corporation(ULBI)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Energous Corporation and potential small cap networking or power peer Acacia Communications (NASDAQ: ACIA) having a run up late last year while small cap Ultralife Corp (NASDAQ: ULBI) is heading back up to previous highs and EnSync Inc (NYSEMKT: ESNC) has underperformed:

Top 10 Heal Care Stocks To Buy Right Now: Wells Fargo & Company(WFC)

Advisors’ Opinion:

  • [By ]

    2. Low Debt Levels
    By looking through his previous success stories like Coca-Cola (NYSE: KO), American Express (NYSE: AXP), and Wells Fargo (NYSE: WFC), it is clear that Buffett carefully examines a company’s balance sheet, and prefers to invest in those with relatively modest debt burdens.

  • [By Todd Shriber, ETF Professor]

    Well-known stocks in that group include JPMorgan Chase & Co. (NYSE: JPM), Wells Fargo & Co (NYSE: WFC) and Bank of America Corp. (NYSE: BAC).

  • [By Dan Caplinger]

    Wells Fargo (NYSE:WFC) did an exceptionally good job of making it through the financial crisis in 2008 with minimal damage, weathering the turbulence in its stock price and rising to all-time record highs in the early and mid-2010s. Along the way, Wells Fargo also sought to regain its standing as a strong dividend stock, and it has successfully restored its quarterly payout to levels above what it had paid prior to the crisis. Yet recently, the bank has run into controversy with a scandal involving employees opening fake accounts, and Wells Fargo’s most recent earnings weren’t as strong as the company has seen in the past. Some investors are wondering whether the bank’s track record of dividend increases since the financial crisis could be in jeopardy. Let’s look more closely to whether Wells Fargo will raise its dividend in 2017.

  • [By SEEKINGALPHA.COM]

    The US financial sector has been on a solid run of late. Over the last 12 months the S&P 500 Financials Sector has returned 18.9% relative to the S&P 500 Index of 17.9%. Many analysts have formed the view that with the potential for higher market interest rates, this sector has a long runway ahead. So with this in mind I thought that it would be a good time to update my estimates of the intrinsic value of the 3 major diversified banks. Over a series of 4 articles I will value JPMorgan (NYSE: JPM), Wells Fargo (NYSE: WFC) and Bank of America (NYSE: BAC). In this first article I will set the scene by reviewing the performance of the 3 banks over the last 10 years and compare their current performance to the Sector.

Top 10 Heal Care Stocks To Buy Right Now: Cherokee Inc.(CHKE)

Advisors’ Opinion:

  • [By Lisa Levin]

    Cherokee Inc (NASDAQ: CHKE) shares dropped 37 percent to $4.85 after the company reported a loss for its first quarter on Thursday. The company reported an adjusted loss of $0.07 per share, versus analysts’ estimates for a profit of $0.13 per share.

  • [By Lisa Levin]

    Cherokee Inc (NASDAQ: CHKE) shares dropped 32 percent to $5.26 after the company reported a loss for its first quarter on Thursday. The company reported an adjusted loss of $0.07 per share, versus analysts’ estimates for a profit of $0.13 per share.

Top 10 Heal Care Stocks To Buy Right Now: Gerdau S.A.(GGB)

Advisors’ Opinion:

  • [By Manikandan Raman]

    On the news, Freeport-McMoRan surged 12 percent to $10.20 and Lundin Mining climbed 12 percent to $3.33. Gerdau SA (ADR) (NYSE: GGB) rose 19 percent to $1.23, Vale SA (ADR) (NYSE: VALE) advanced 18 percent to $4.85 and Banco Bradesco SA (ADR) (NYSE: BBD) gained 11 percent to $7.15.

Top 10 Heal Care Stocks To Buy Right Now: Compass Minerals Intl Inc(CMP)

Advisors’ Opinion:

  • [By Monica Gerson]

    Compass Minerals International, Inc. (NYSE: CMP) is projected to post its quarterly earnings at $1.33 per share on revenue of $347.03 million.

    MKS Instruments, Inc. (NASDAQ: MKSI) is estimated to post its quarterly earnings at $0.33 per share on revenue of $177.19 million.

Top 10 Heal Care Stocks To Buy Right Now: Tutor Perini Corporation(TPC)

Advisors’ Opinion:

  • [By Casey Wilson]

    Take general contracting company Tutor Perini (NYSE: TPC), for example.

    The California-based contracting giant is responsible for funding many infrastructure projects, including “Big Bertha,” a huge tunnel-boring project in Seattle, Wash. This tunnel will be 9,270 feet long and 115 feet deep – allowing for a major highway to be carried under downtown Seattle.

Top 10 Warren Buffett Stocks To Buy For 2018

Related FB Facebook Is Quietly Supporting This Satellite Company With 40% Upside Report: Google's VR Headset Doesn't Rely On A Smartphone Facebook, Alphabet, LinkedIn: Which Makes The Warren Buffett Screen? (Investor’s Business Daily)

Tech companies have been toeing a fine line between protecting their users' privacy and complying with government requests to provide them with what they think is essential information in combating terrorism. Terror groups are becoming increasingly active on social media, using sites like Twitter Inc (NYSE: TWTR) and Facebook Inc (NASDAQ: FB) to recruit new members, plan attacks and spread propaganda.

Top 10 Warren Buffett Stocks To Buy For 2018: Innoviva, Inc. (INVA)

Advisors’ Opinion:

  • [By Sean Williams]

    Shares of Innoviva (NASDAQ:INVA), a biotechnology royalty company that develops respiratory therapeutics and is perhaps best known as GlaxoSmithKline’s (NYSE:GSK) development partner for its multiple next-generation COPD and asthma products, fell as much as 11% on Thursday. The reason behind Innoviva’s bad day can be traced to a proxy battle with activist hedge fund Sarissa Capital Management over seats on its board.

Top 10 Warren Buffett Stocks To Buy For 2018: PCM, Inc.(PCMI)

Advisors’ Opinion:

  • [By Lisa Levin]

    PCM Inc (NASDAQ: PCMI) was down, falling around 26 percent to $14.63. PCM reported Q2 adjusted earnings of $0.47 per share on sales of $560.1 million.

Top 10 Warren Buffett Stocks To Buy For 2018: Ultralife Corporation(ULBI)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Energous Corporation and potential small cap networking or power peer Acacia Communications (NASDAQ: ACIA) having a run up late last year while small cap Ultralife Corp (NASDAQ: ULBI) is heading back up to previous highs and EnSync Inc (NYSEMKT: ESNC) has underperformed:

Top 10 Warren Buffett Stocks To Buy For 2018: Karyopharm Therapeutics Inc.(KPTI)

Advisors’ Opinion:

  • [By Chris Lange]

    Karyopharm Therapeutics Inc. (NASDAQ: KPTI) was raised to a Buy rating from Hold, and the price target was increased to $12 from $9, at Jefferies. The firm said its call is based on its future revenue opportunity in multiple myeloma. Itsshares most recently closed at $10.62, with a consensus price target of $16.30 and a 52-week range of $4.83 to $19.41.

Top 10 Warren Buffett Stocks To Buy For 2018: Orbital ATK, Inc.(OA)

Advisors’ Opinion:

  • [By Jim Powell]

    My top recommendation for the privatization of space is Orbital ATK (OA), which was was formed early last year from the merger of Orbital Sciences and the aerospace division of Alliant Techsystems.

  • [By Rich Smith]

    On one particularly big news day, April 28, the DSCA announced that it has notified Congress of no fewer than seven separate pending arms sales that it plans to push through. These deals are aiming to sell:

    110 radar-seeking air-to-ground “HARM” missiles to Australia, generating sales of $137.6 million for prime contractors Orbital ATK (NYSE:OA) and Raytheon (NYSE:RTN). Four P-8A Poseidonsubmarine-hunting jet aircraft to New Zealand — a $1.46 billion payday for Boeing (NYSE:BA). 13 76 mm cannonfor installation aboard Israeli Navy SA’AR 4.5 and SA’AR 6 Missile Patrol Boats at a purchase price of $440 million. (Italian firm Leonardo S.p.a.’s DRS North America subsidiary will be the contractor on that one.) Nine Bell 429light utility helicopters to Slovakia, yielding sales of $150 million for Textron (NYSE:TXT). And five CH-47D Chinookhelicopters, sold out of U.S. government surplus to Greece for $80 million.

    Also included in the DSCA’s list of pending contracts are two directed toward the NATO Support and Procurement Agency, specifically:

  • [By Rich Smith]

    Now consider that as of the last report, Americans owned 265 million guns — but fewer than 1 million silencers. That’s a huge market that American Outdoor Brands and Sturm, Ruger would love to sell into. Easing restrictions on silencer sales could have follow-on effects, too. Granting easier access to suppressors could reduce noise complaints at open-air shooting ranges, making it easier for such businesses to open, which would attract more customers, resulting in more ammunition being used, resulting in more ammunition being sold, resulting in more sales (and profits) for ammo makers such as Olin Corp (NYSE:OLN), Vista Outdoor (NYSE:VSTO), and Orbital ATK (NYSE:OA).

  • [By Lisa Levin]

    Defense giant Northrop Grumman Corporation (NYSE: NOC) confirmed Monday it will buy Orbital ATK Inc (NYSE: OA), the maker of the Pegasus rocket and a vast array of other aerospace and defense systems, in a $9.2 billion deal.

  • [By Jim Robertson]

    Last Monday, U.S. defense contractor Northrop Grumman Corporation (NYSE: NOC) announced it would buy Orbital ATK Inc (NYSE: OA), a direct Aerojet Rocketdyne competitor,for about $7.8 billion (a 22% premium to Orbital’s Friday close) in a deal thatwill give it greater access to lucrative government contracts and expand its arsenal of missile defense systems and space rockets. While Northrop already has a significant presence in payloads, it has not had launcher capability, an area that Orbital brings for both space and missile defense. Orbital also has contracts with NASA and the U.S. Army. The all-cash transaction is the biggest in the defense sector in two years and comes ahead of planned upgrades of U.S. ballistic systems (as the saber rattling by North Korea continues), which are expected to drive demand for missiles.

  • [By Rich Smith]

    While Trump’s nuclear tweet appears to have taken some folks off guard, the fact is that the U.S. has been planning a major upgrade and refurbishmentof its nuclear arsenal for quite some time — since at least the early years of the second Obama administration, in fact. As far back as three years ago, we were writing about a U.S. Air Force effort to begin upgrading the nation’s aging fleet of Minuteman III intercontinental ballistic missiles — a contract that Aerojet Rocketdyne (NYSE:AJRD), among others, is counting on to juice its rocket revenues. Rival rocket scientist Orbital ATK (NYSE:OA) is bidding on the same contract, and whether it’s Aerojet or Orbital that eventually ends up winning this piece of the nuclear rearmament project, there should be money aplenty to go around.

Top 10 Warren Buffett Stocks To Buy For 2018: American DG Energy Inc.(ADGE)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Thursday, our Under the Radar Moversnewsletter suggested small cap green energy stock American DG Energy (NYSEMKT: ADGE) as a long trade:

    As for American DG Energy, today’s push above a technical ceiling at $0.34 is telling, though that clue is made more telling when you see the short-term moving average lines have given us key bullish crosses over the course of the past couple of months; the undertow is turning bullish. What you can’t see on the daily chart is that this is the first time in years we’ve seen higher lows logged for ADGE.

Top 10 Warren Buffett Stocks To Buy For 2018: Taylor & Martin Group Inc (TMG)

Advisors’ Opinion:

  • [By Jim Cramer]

    THERMO FISHER SCIENTIFIC INC’s earnings per share improvement from the most recent quarter was slightly positive. The company has demonstrated a pattern of positive earnings per share growth over the past two years. We feel that this trend should continue. During the past fiscal year, THERMO FISHER SCIENTIFIC INC increased its bottom line by earning $4.70 versus $3.49 in the prior year. This year, the market expects an improvement in earnings ($7.39 versus $4.70).

     

  • [By Jim Cramer]

    Net operating cash flow has increased to $743.90 million or 10.04% when compared to the same quarter last year. In addition, THERMO FISHER SCIENTIFIC INC has also modestly surpassed the industry average cash flow growth rate of 0.44%.

     

  • [By Jim Cramer]

    The net income growth from the same quarter one year ago has exceeded that of the S&P 500 and the Life Sciences Tools & Services industry average. The net income increased by 0.9% when compared to the same quarter one year prior, going from $471.60 million to $476.10 million.

     

  • [By Laurie Kulikowski]

    We rate THERMO FISHER SCIENTIFIC INC as a Buy with a ratings score of A+. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company’s strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income, reasonable valuation levels, good cash flow from operations and growth in earnings per share. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. 

  • [By Jim Cramer]

    The stock has risen over the past year as investors have generally rewarded the company for its earnings growth and other positive factors like the ones we have cited in this report. Turning our attention to the future direction of the stock, it goes without saying that even the best stocks can fall in an overall down market. However, in any other environment, this stock still has good upside potential despite the fact that it has already risen in the past year.

     

Top 10 Warren Buffett Stocks To Buy For 2018: North American Energy Partners, Inc.(NOA)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Tuesday, energy shares slipped by 1.36 percent. Meanwhile, top losers in the sector included Northern Oil & Gas, Inc. (NYSE: NOG), down 9 percent, and North American Energy Partners Inc.(USA) (NYSE: NOA), down 6 percent.

Top 10 Warren Buffett Stocks To Buy For 2018: ClubCorp Holdings, Inc.(MYCC)

Advisors’ Opinion:

  • [By Steve Symington]

    Shares of ClubCorp Holdings Inc. (NYSE:MYCC) jumped 15.7% Thursday after reports stating the private golf and country-club specialist is considering strategic alternatives.

Top 10 Warren Buffett Stocks To Buy For 2018: Alliance Fiber Optic Products, Inc.(AFOP)

Advisors’ Opinion:

  • [By Monica Gerson]

    Alliance Fiber Optic Products (NASDAQ: AFOP) shares rose 7.21% to $21.70. The volume of Alliance Fiber Optic Products shares traded was 397% higher than normal. Alliance Fiber Optic lifted its Q3 revenue outlook.

  • [By Lisa Levin]

    Alliance Fiber Optic Products Inc (NASDAQ: AFOP) shares shot up 19 percent to $18.47 after the company agreed to be acquired by Corning Incorporated (NYSE: GLW) for $18.50 per share.